CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 13 filers reported holding CNS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $142,000 | +30.3% | 59,565 | -2.8% | 0.02% | +21.4% |
Q4 2020 | $109,000 | +0.9% | 61,307 | -0.4% | 0.01% | -6.7% |
Q3 2020 | $108,000 | -28.9% | 61,563 | -13.5% | 0.02% | -40.0% |
Q2 2020 | $152,000 | +1.3% | 71,148 | -0.5% | 0.02% | -16.7% |
Q1 2020 | $150,000 | -51.0% | 71,494 | -7.7% | 0.03% | -21.1% |
Q4 2019 | $306,000 | – | 77,458 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 534,148 | $951,000 | 0.36% |
CVI Holdings, LLC | 415,652 | $740,000 | 0.14% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 61,307 | $109,000 | 0.01% |
Warberg Asset Management LLC | 14,000 | $25,000 | 0.01% |
Alpha Cubed Investments, LLC | 10,000 | $18,000 | 0.00% |
Integrated Advisors Network LLC | 10,700 | $19,000 | 0.00% |
Core Wealth Advisors, Inc. | 550 | $1,000 | 0.00% |
OSAIC HOLDINGS, INC. | 5,000 | $9,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 41 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |